Literature DB >> 19917873

Thiazide diuretics alone or with beta-blockers impair glucose metabolism in hypertensive patients with abdominal obesity.

Camila Manrique, Megan Johnson, James R Sowers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19917873      PMCID： PMC2796286          DOI： 10.1161/HYPERTENSIONAHA.109.142620

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  10 in total

1.  Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.

Authors:  William J Elliott; Peter M Meyer
Journal:  Lancet       Date:  2007-01-20       Impact factor: 79.321

Review 2.  Effect of antihypertensive agents on the development of type 2 diabetes mellitus.

Authors:  Craig S Stump; Marc T Hamilton; James R Sowers
Journal:  Mayo Clin Proc       Date:  2006-06       Impact factor: 7.616

3.  Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:  Joshua I Barzilay; Barry R Davis; Jeffrey A Cutler; Sara L Pressel; Paul K Whelton; Jan Basile; Karen L Margolis; Stephen T Ong; Laurie S Sadler; John Summerson
Journal:  Arch Intern Med       Date:  2006-11-13

4.  Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

Authors:  George L Bakris; Vivian Fonseca; Richard E Katholi; Janet B McGill; Franz H Messerli; Robert A Phillips; Philip Raskin; Jackson T Wright; Rosemary Oakes; Mary Ann Lukas; Karen M Anderson; David S H Bell
Journal:  JAMA       Date:  2004-11-10       Impact factor: 56.272

Review 5.  Risk factor assessment for new onset diabetes: literature review.

Authors:  George Bakris; Jack Stockert; Mark Molitch; Qian Zhou; Annette Champion; Peter Bacher; James Sowers
Journal:  Diabetes Obes Metab       Date:  2008-06-16       Impact factor: 6.577

6.  Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study.

Authors:  Jan W Eriksson; Per-Anders Jansson; Bo Carlberg; Anders Hägg; Lisa Kurland; Maria K Svensson; Håkan Ahlström; Conny Ström; Lars Lönn; Kristina Ojbrandt; Lars Johansson; Lars Lind
Journal:  Hypertension       Date:  2008-11-03       Impact factor: 10.190

7.  Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up.

Authors:  Torbjörn Almgren; Lars Wilhelmsen; Ola Samuelsson; Anders Himmelmann; Annika Rosengren; Ove K Andersson
Journal:  J Hypertens       Date:  2007-06       Impact factor: 4.844

8.  Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications.

Authors:  Rhonda M Cooper-DeHoff; Sheron Wen; Amber L Beitelshees; Issam Zineh; John G Gums; Stephen T Turner; Yan Gong; Karen Hall; Vishal Parekh; Arlene B Chapman; Eric Boerwinkle; Julie A Johnson
Journal:  Hypertension       Date:  2009-11-16       Impact factor: 10.190

Review 9.  Metabolic syndrome and incident diabetes: current state of the evidence.

Authors:  Earl S Ford; Chaoyang Li; Naveed Sattar
Journal:  Diabetes Care       Date:  2008-06-30       Impact factor: 19.112

Review 10.  Realities of newer beta-blockers for the management of hypertension.

Authors:  Camila Manrique; Thomas D Giles; Keith C Ferdinand; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-07       Impact factor: 3.738
  10 in total
  11 in total

1.  Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat.

Authors:  Xinli Zhou; Lixin Ma; Javad Habibi; Adam Whaley-Connell; Melvin R Hayden; Roger D Tilmon; Ashley N Brown; Jeong-A Kim; Vincent G Demarco; James R Sowers
Journal:  Hypertension       Date:  2010-02-22       Impact factor: 10.190

2.  Nebivolol improves insulin sensitivity in the TGR(Ren2)27 rat.

Authors:  Camila Manrique; Guido Lastra; Javad Habibi; Lakshmi Pulakat; Rebecca Schneider; William Durante; Roger Tilmon; Jenna Rehmer; Melvin R Hayden; Carlos M Ferrario; Adam Whaley-Connell; James R Sowers
Journal:  Metabolism       Date:  2011-06-02       Impact factor: 8.694

3.  Inadequacies of current approaches to prediabetes and diabetes prevention.

Authors:  Michael Bergman
Journal:  Endocrine       Date:  2013-07-24       Impact factor: 3.633

4.  Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives.

Authors:  James R Sowers; Leopoldo Raij; Ishwaral Jialal; Brent M Egan; Elizabeth O Ofili; Rita Samuel; Dion H Zappe; Das Purkayastha; Prakash C Deedwania
Journal:  J Hypertens       Date:  2010-08       Impact factor: 4.844

Review 5.  Type 2 diabetes mellitus and hypertension: an update.

Authors:  Guido Lastra; Sofia Syed; L Romayne Kurukulasuriya; Camila Manrique; James R Sowers
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

6.  Diabetes mellitus and vascular disease.

Authors:  James R Sowers
Journal:  Hypertension       Date:  2013-05       Impact factor: 10.190

7.  Gene expression in thiazide diuretic or statin users in relation to incident type 2 diabetes.

Authors:  Astrid Suchy-Dicey; Susan R Heckbert; Nicholas L Smith; Barbara McKnight; Jerome I Rotter; Yd Ida Chen; Bruce M Psaty; Daniel A Enquobahrie
Journal:  Int J Mol Epidemiol Genet       Date:  2014-02-17

Review 8.  Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus.

Authors:  Michael Bergman
Journal:  Endocrine       Date:  2012-11-07       Impact factor: 3.633

9.  Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial.

Authors:  Morris J Brown; Bryan Williams; Steve V Morant; David J Webb; Mark J Caulfield; J Kennedy Cruickshank; Ian Ford; Gordon McInnes; Peter Sever; Jackie Salsbury; Isla S Mackenzie; Sandosh Padmanabhan; Thomas M MacDonald
Journal:  Lancet Diabetes Endocrinol       Date:  2015-10-18       Impact factor: 32.069

10.  The effects of antihypertensive drugs on chromium status, glucose metabolism, and antioxidant and inflammatory indices in spontaneously hypertensive rats.

Authors:  Joanna Suliburska; Zbigniew Krejpcio; Halina Staniek; Ewelina Król; Pawel Bogdanski; Justyna Kupsz; Iwona Hertig
Journal:  Biol Trace Elem Res       Date:  2013-11-19       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.